In studying "hemorrhagic necrosis" of tumors produced by endotoxin, it was found that the serum of bacillus Calmette-Guerin (BCG)infected mice treated with endotoxin contains a substance (tumor necrosis factor; TNF) which mimics the tumor necrotic action of endotoxin itself. TNF-positive serum is as effective as endotoxin itself in causing necrosis of the sarcoma Meth A and other transplanted tumors. A variety of tests indicate that TNF is not residual endotoxin, but a factor released from host cells, probably macrophages, by endotoxin. Corynebacteria and Zymosan, which like BCG induce hyperplasia of the reticulo-endothelial system, can substitute for BCG in priming mice for release of TNF by endotoxin. TNF is toxic in vitro for two neoplastic cell lines; it is not toxic for mouse embryo cultures. We propose that TNF mediates endotoxin-induced tumor necrosis, and that it may be responsible for the suppression of transformed cells by activated macrophages.
One of the best-known enigmas of cancer biology is the "hemorrhagic necrosis" of tumors induced by endotoxin (1) (2) (3) (4) (5) . We report here that endotoxin acts indirectly by causing the host to release a substance, which we name tumor necrosis factor (TNF), that is selectively toxic for malignant 
RESULTS

Assay for tumor necrosis factor (TNF) in serum
The criterion adopted as a standard for assaying TNF in the sera of mice subjected to various treatments (see below) was visual observation of necrosis in a subcutaneous transplant of BALB/c sarcoma Meth A. Fig. 1 illustrates the grades of response (-to +++) elicited in individual (BALB/c X C57BL/6)F1 mice by administration of serum containing TNF. In the maximum (+++) response, the major part of the tumor mass is destroyed, leaving only a peripheral rim of apparently viable tumor tissue. In about 25% of mice treated with 0.5 ml of TNF-positive serum, the tumor regresses. Regression is not seen in control untreated mice under these conditions. Mice receiving TNF-positive serum show no marked signs of toxicity.
Necessity for treatment with both BCG and endotoxin for the production of TNF in the serum In the studies summarized in Table 1 Zymosan (2000 mug) 4 * CD-1 Swiss mice received the eliciting agent 14 days after the priming agent (both iv) and were exsanguinated 2 hr later.
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Immunology: Carswell et al. DISCUSSION The inhibitory effect of bacterial products on human cancer has long been known (9) . The counterpart in laboratory animals has been regarded as the "hemorrhagic necrosis" of transplanted tumors caused by material from Gram-negative bacteria. Much early work culminated in Shear's isolation of a tumor-necrosing "polysaccharide" (10), now recognized as endotoxin. The fact that endotoxin does not kill tumor cells in culture indicated that its action must be indirect, and lent credence to Algire's conclusion (11) that hemorrhagic necrosis might be secondary to endotoxin-induced hypotension leading to circulatory stasis and ischemia in the tumor. The discovery of TNF provides a more obvious rationale for the indirect action of endotoxin, namely, that endo- (13) . Can TNF be identified with any of the factors already known to be elicited by endotoxin? So far we can exclude interferon, which, although abundant in TNF sera, is absent from partially purified TNF. Creactive protein has been ruled out, and the stability of TNF at 560 excludes any heat-labile factor.
The cellular origin of TNF is uncertain, but the fact that macrophage-inciting agents are necessary for its demonstration in serum points to this cell as the source. This interpretation is strongly supported by recent observations we have made on TNF-donor mice (S. Sternberg, unpublished data). In the greatly enlarged spleens of BCG-infected mice, microscopy shows massive hyperplasia of macrophages; two hours after administration of endotoxin, at the time when TNF is abundant in the blood, there is pyknosis and disruption of this cell population.
One of the most provocative findings about macrophages in recent years is that when nonspecifically "activated" by agents such as BCG, endotoxin, and certain protozoa, they acquire selective toxicity for malignant cells (14) (15) (16) (17) . The fact that TNF in vitro showed discriminatory toxicity for transformed cells in our present study might suggest that TNF mediates the selective cytotoxicity of activated macrophages.
To explore the full potential of TNF, a more plentiful source will be required. Extraction from liver and spleen of mice with RES hyperplasia produced by BCG or C. parvum is one possibility; but the fact that the rat and rabbit produce TNF suggests the use of larger animals for preparing TNF in quantity.
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